Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

iRhythm Technologies, Inc. - Common Stock (NQ:IRTC)

140.10 +2.30 (+1.67%)
Streaming Delayed Price Updated: 12:56 PM EDT, May 13, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 173,911
Open 138.11
Bid (Size) 139.90 (2)
Ask (Size) 140.29 (2)
Prev. Close 137.80
Today's Range 137.90 - 140.64
52wk Range 55.92 - 141.39
Shares Outstanding 29,403,360
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Pony AI, Hims & Hers And Frontdoor Are Among Top 11 Mid-Cap Gainers Last Week (Apr 28-May 2): Are The Others In Your Portfolio?
Top performers last week: PONY, HIMS, ODD, MTSR, CGON, KNSA, KC, FTDR, ATI, PRDO, and IRTC. Have you invested in them? 
Via Benzinga
Topics Artificial Intelligence
Exposures Artificial Intelligence
Zio Demand Drives 20% Revenue Growth For iRhythm, Bullish Sentiment Builds Among Analysts
iRhythm raises 2025 sales forecast and launches Zio ECG system in Japan as analysts boost ratings and price targets on strong Q1 performance. 
Via Benzinga

Performance

YTD
+56.6%
+56.6%
1 Month
+35.8%
+35.8%
3 Month
+27.9%
+27.9%
6 Month
+57.5%
+57.5%
1 Year
+41.7%
+41.7%

More News

Read More
Wells Fargo Upgrades iRhythm Technologies Stock, Raises Price Target To $130: Retail’s Thrilled
Via Stocktwits
This FTAI Aviation Analyst Turns Bullish; Here Are Top 2 Upgrades For Friday
Via Benzinga
Earnings Scheduled For May 1, 2025
Via Benzinga
Trupanion Posts Better-Than-Expected Results, Joins Duolingo, DexCom, Exact Sciences And Other Big Stocks Moving Higher On Friday
Via Benzinga
Deep Dive Into iRhythm Technologies Stock: Analyst Perspectives (5 Ratings)
Via Benzinga
iRhythm (NASDAQ:IRTC) Surprises With Strong Q1, Full-Year Sales Guidance is Optimistic
Via StockStory
iRhythm Launches Zio® Long-Term Continuous Monitoring Service in Japan as the Zio® ECG Recording and Analysis System, Advancing AI-Powered Arrhythmia Detection
From iRhythm
Via GlobeNewswire
iRhythm Technologies Announces First Quarter 2025 Financial Results
From iRhythm
Via GlobeNewswire
iRhythm Earnings: What To Look For From IRTC
Via StockStory
Topics Artificial Intelligence Economy World Trade
Exposures Artificial Intelligence Economy Tariff
iRhythm Technologies to Present at the Bank of America Securities 2025 Health Care Conference
From iRhythm
Via GlobeNewswire
iRhythm Presents New Real-World Data on Ambulatory Cardiac Monitoring at HRS 2025 Reinforcing Clinical Superiority of Zio Long-Term Continuous Monitoring
From iRhythm
Via GlobeNewswire
iRhythm Technologies to Report First Quarter 2025 Financial Results on May 1, 2025
From iRhythm
Via GlobeNewswire
iRhythm Technologies Releases 2024 Corporate Sustainability Report That Demonstrates Ongoing Commitment to Culture of Quality and Sustainability
From iRhythm
Via GlobeNewswire
3 Reasons IRTC is Risky and 1 Stock to Buy Instead
Via StockStory
Topics Bankruptcy
Exposures Financial Legal
Q4 Patient Monitoring Earnings Review: First Prize Goes to Masimo (NASDAQ:MASI)
Via StockStory
Topics Artificial Intelligence
Exposures Artificial Intelligence
1 Small-Cap Stock Worth Your Attention and 2 to Question
Via StockStory
Q4 Earnings Highlights: iRhythm (NASDAQ:IRTC) Vs The Rest Of The Patient Monitoring Stocks
Via StockStory
Topics Artificial Intelligence
Exposures Artificial Intelligence
iRhythm Unveils New Real-World Data at ACC.25 Demonstrating the Benefits of Zio® Long-Term Continuous Monitoring for Arrhythmia Detection
From iRhythm
Via GlobeNewswire
3 Healthcare Stocks in the Doghouse
Via StockStory
Topics Stocks
Exposures COVID-19 US Equities
Patient Monitoring Stocks Q4 In Review: Insulet (NASDAQ:PODD) Vs Peers
Via StockStory
Topics Artificial Intelligence
Exposures Artificial Intelligence
Patient Monitoring Stocks Q4 Results: Benchmarking ResMed (NYSE:RMD)
Via StockStory
Topics Artificial Intelligence
Exposures Artificial Intelligence
Why Dexcom Is On A Six-Day Losing Spree — But This Analyst Isn't Worried
Via Investor's Business Daily
1 Growth Stock to Target This Week and 2 to Ignore
Via StockStory

Frequently Asked Questions

Is iRhythm Technologies, Inc. - Common Stock publicly traded?
Yes, iRhythm Technologies, Inc. - Common Stock is publicly traded.
What exchange does iRhythm Technologies, Inc. - Common Stock trade on?
iRhythm Technologies, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for iRhythm Technologies, Inc. - Common Stock?
The ticker symbol for iRhythm Technologies, Inc. - Common Stock is IRTC on the Nasdaq Stock Market
What is the current price of iRhythm Technologies, Inc. - Common Stock?
The current price of iRhythm Technologies, Inc. - Common Stock is 140.10
When was iRhythm Technologies, Inc. - Common Stock last traded?
The last trade of iRhythm Technologies, Inc. - Common Stock was at 05/13/25 12:56 PM ET
What is the market capitalization of iRhythm Technologies, Inc. - Common Stock?
The market capitalization of iRhythm Technologies, Inc. - Common Stock is 4.12B
How many shares of iRhythm Technologies, Inc. - Common Stock are outstanding?
iRhythm Technologies, Inc. - Common Stock has 4B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.